Menu Menu

SLS    Sellas Life Sciences Group Inc    1390478    
Income Statement
Net Income -7,108,000

Balance Sheet
Current Assets 24,035,000
Assets 26,505,000
Current Liabilities 10,613,000
Liabilities 10,613,000
Equity 15,892,000
Shares Out 64,332,000

Cash Flow Statement
Operating Cash Flow -28,249,000

Market Analysis
Market Cap 82,988,922
Price 1.06
BVPS 0.25
PB 4.21
EPS -0.93
PS 0.85
FCF -28,249,000
Dividends
Jan Feb Mar
Apr May Jun
Jul Aug Sep
Oct Nov Dec

Earnings
Jan Feb Mar
-0.34
Apr May Jun
5/14 -0.21
Jul Aug Sep
8/13 -0.13
Oct Nov Dec
11/07

Find a discrepancy? The most accurate way to find company fundamental data is to view SLS documents filed with the SEC.


SLS Filings       Clear



Find balance sheet, income statement, market analysis, and dividend information by typing the ticker symbol of a company.

Ticker: